Even for early-onset AD, the APOE4 variant is associated with earlier onset and harsher severity, including elevating levels of the amyloid-β1-40 peptide and faster spread of neurodegeneration in the case of Down syndrome (Patel et al. 2011; Head et al. 2011). This evidence concerns the gene APOE and Down syndrome.